Ronna E. Dornsife - Concepedia

Author

Ronna E. Dornsife

Also Known As

Asquith, Christopher R. M., Dornsife, Ronna E., J Kurtzberg, R E Dornsife, R. Dornsife, R. E. DORNSIFE, R. E. Dornsife, R.E. Dornsife, Ronna E Dornsife, Ronna E. Dornsife

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Research Triangle Park Foundation Colorado State University Burroughs Wellcome Fund University of Michigan University of North Carolina at Chapel Hill

About

Ronna E. Dornsife is an author at Research Triangle Park Foundation specializing in medicine, virology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	1.3K
2	Natural Sciences	6	6	890
3	Biochemistry	6	6	890
4	Biomolecular Engineering	2	2	376
5	Allergy	1	1	17

Ronna E. Dornsife

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human immunodeficiency virus activity Susan M. Daluge, Steven S. Good, M B Faletto, Antimicrobial Agents and Chemotherapy ImmunologyPharmacotherapyAntiviral DrugPharmaceutical ChemistryMolecular Pharmacology	1997	384
Potent and Selective Inhibition of Human Cytomegalovirus Replication by 1263W94, a Benzimidazole <scp>l</scp> -Riboside with a Unique Mode of Action Karen K. Biron, Richard J. Harvey, Stanley C. Chamberlain, Antimicrobial Agents and Chemotherapy Viral ReplicationUnique ModeMolecular BiologyAntiviral DrugDrug Resistance	2002	361
The anti-hepatitis B virus activities, cytotoxicities, and anabolic profiles of the (-) and (+) enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine P A Furman, M. Davis, Dennis C. Liotta, Antimicrobial Agents and Chemotherapy	1992	234
Correction of feline arylsulphatase B deficiency (mucopolysaccharidosis VI) by bone marrow transplantation Peter W. Gasper, M. A. Thrall, David A. Wenger, Nature Bone Marrow FailureMarrow TransplantationHematologyImmunologyPathology	1984	86
Anti-human immunodeficiency virus synergism by zidovudine (3'-azidothymidine) and didanosine (dideoxyinosine) contrasts with their additive inhibition of normal human marrow progenitor cells Ronna E. Dornsife, M H St Clair, A T Huang, Antimicrobial Agents and Chemotherapy Antiviral CompoundHuman RetrovirusHematologyImmunologyPharmacology	1991	80
Pathogenic and host range determinants of the feline aplastic anemia retrovirus. N Riedel, E A Hoover, Ronna E. Dornsife, Proceedings of the National Academy of Sciences Viral ReplicationImmunologyViral PathogenesisPathologyAplastic Anemia	1988	71
Identification and Optimization of 4‐Anilinoquinolines as Inhibitors of Cyclin G Associated Kinase Christopher R. M. Asquith, Tuomo Laitinen, James M. Bennett, ChemMedChem	2017	57
Antiviral, metabolic, and pharmacokinetic properties of the isomeric dideoxynucleoside 4(S)-(6-amino-9H-purin-9-yl)tetrahydro-2(S)-furanmethanol V. NAIR, M H St Clair, John E. Reardon, Antimicrobial Agents and Chemotherapy Pharmaceutical ScienceBioorganic ChemistryPharmacotherapyAntimicrobial ChemotherapyAntiviral Drug	1995	51
Influence of stereochemistry on antiviral activities and resistance profiles of dideoxycytidine nucleosides N. A. VAN DRAANEN, Margaret Tisdale, N. R. Parry, Antimicrobial Agents and Chemotherapy Hiv-1 ResistanceImmunologyPharmacotherapyAntiviral DrugDrug Resistance	1994	51
Antitumour efficacy of VEGFR2 tyrosine kinase inhibitor correlates with expression of VEGF and its receptor VEGFR2 in tumour models I K Dev, Ronna E. Dornsife, Teresa M. Hopper, British Journal of Cancer Antitumour EfficacyPathologyPharmacotherapyTumor BiologyAngiogenesis	2004	43

Page 1